paroxetine has been researched along with flupenthixol in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansen, JB; Kristiansen, JE | 1 |
Soomro, GM | 3 |
Ebert, LC; Fornaro, J; Gascho, D; Kraemer, T; Laberke, P; Martinez, RM; Staeheli, SN; Steuer, AE; Thali, MJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Brincat, JP; Carosati, E; Cruciani, G; Fravolini, A; Kaatz, GW; Manfroni, G; Patel, D; Raygada, JL; Sabatini, S | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
3 review(s) available for paroxetine and flupenthixol
Article | Year |
---|---|
Deliberate self harm.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Behavior Therapy; Continuity of Patient Care; Flupenthixol; Hospitalization; Humans; Paroxetine; Psychotherapy; Self-Injurious Behavior; Suicide Prevention | 2003 |
Deliberate self harm.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cognitive Behavioral Therapy; Continuity of Patient Care; Flupenthixol; Hospitalization; Humans; Mianserin; Paroxetine; Psychotherapy; Self-Injurious Behavior; Suicide Prevention | 2004 |
Deliberate self harm (and attempted suicide).
Topics: Antidepressive Agents, Second-Generation; Flupenthixol; Humans; Mianserin; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Suicide, Attempted | 2005 |
5 other study(ies) available for paroxetine and flupenthixol
Article | Year |
---|---|
Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia.
Topics: Antibodies, Monoclonal; Antidepressive Agents; Antipsychotic Agents; Cell Line; Flupenthixol; gag Gene Products, Human Immunodeficiency Virus; Gene Products, gag; HIV Antigens; HIV Core Protein p24; HIV-1; Humans; Immunohistochemistry; Paroxetine; Piperidines; Viral Proteins; Virus Replication | 2000 |
Development of CT-guided biopsy sampling for time-dependent postmortem redistribution investigations in blood and alternative matrices--proof of concept and application on two cases.
Topics: Autopsy; Chromatography, Liquid; Desvenlafaxine Succinate; Equipment Design; Female; Flupenthixol; Forensic Toxicology; Humans; Image-Guided Biopsy; Lorazepam; Middle Aged; Paroxetine; Postmortem Changes; Robotics; Tandem Mass Spectrometry; Time Factors; Tissue Distribution; Tomography, X-Ray Computed; Venlafaxine Hydrochloride | 2016 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Ciprofloxacin; Databases, Factual; Drug Resistance, Bacterial; Drug Synergism; Ethidium; Microbial Sensitivity Tests; Models, Molecular; Multidrug Resistance-Associated Proteins; Phenyl Ethers; Propanolamines; Quantitative Structure-Activity Relationship; Staphylococcus aureus; Structure-Activity Relationship; Sulfonamides | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |